Table 1.
Antibiotic | Number and % of patients* |
---|---|
| |
Fluoroquinolones | 65994 (33%) |
Besifloxacin | |
Ciprofloxacin | |
Gatifloxacin | |
Levofloxacin | |
Moxifloxacin | |
Ofloxacin | |
| |
Aminoglycosides | 22651 (11%) |
Gentamycin | |
Tobramycin | |
| |
Polymyxins | 31070 (16%) |
Polymyxin/Bacitracin | |
Polymycin/Bacitracin/Neomycin | |
Polymyxin/Neomycin/Gramicidin | |
Polymyxin/Trimethoprim | |
| |
Sulfonamides | 14463 (7%) |
Sulfacetamide | |
| |
Macrolides | 34815 (18%) |
Erythromycin | |
Azithromycin | |
| |
Bacitracin | 606 (0.3%) |
Bacitracin | |
| |
Antibiotic-corticosteroid combinations | 38774 (20%) |
Polymycin/Neomycin/Bacitracin/Hydrocortisone | |
Polymyxin/Neomycin/Dexamethasone | |
Polymyxin/Neomycin/Hydrocortisone | |
Sulfacetamide/Prednisolone | |
Tobramycin/Dexamethasone | |
Tobramycin/Loprednol |
Percentage of patients with newly diagnosed acute conjunctivitis who filled >1 prescriptions for topical antibiotics belonging to each antibiotic category within 14 days of initial diagnosis. Some patients may have filled prescriptions for more than one agent in a given class or agents from more than 1 class during the 14 day period so the total number of prescriptions filled does not equal the total number of patients who filled prescriptions.